Alnylam Pharmaceuticals
ALNY
#446
Rank
NZ$90.44 B
Marketcap
NZ$684.58
Share price
-3.65%
Change (1 day)
61.06%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Stock price history for Alnylam Pharmaceuticals (ALNY)

Highest end of day price: NZ$845.88 NZD on 2025-10-20

Lowest end of day price: NZ$6.80 NZD on 2004-08-16

Stock price history of Alnylam Pharmaceuticals from 2004 to 2025

Annual Stock Price Performance

Year Performance
2025 70.17%
2024 20.72%
2023-18.06%
2022 36.65%
2021 32.38%
2020 12.41%
2019 58.29%
2018-44.70%
2017 228.80%
2016-59.75%
2015-3.71%
2014 51.89%
2013 235.42%
2012 110.74%
2011-18.58%
2010-45.64%
2009-29.94%
2008-14.49%
2007 34.82%
2006 65.12%
2005 75.73%
2004 6.71%

Stock price for similar companies or competitors

Company Stock price Change 1d% Country
NZ$120.69-1.03%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$1,277-0.74%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$37.07-1.01%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$2.38-0.72%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$14.05 0.00%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$228.29 0.16%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NZ$83.83-0.37%๐Ÿ‡ซ๐Ÿ‡ท France
NZ$51.30-1.29%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel